Update on Diffuse Alveolar Hemorrhage and Pulmonary Vasculitis

Megan L. Krause, Rodrigo Cartin-Ceba, Ulrich Specks, Tobias Peikert

Research output: Contribution to journalReview articlepeer-review

47 Scopus citations


Diffuse alveolar hemorrhage is a clinical syndrome that can be a manifestation of multiple different causes. Identification of the underlying etiology is of utmost importance and dictates treatment. Pulmonary vasculitis including antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a common cause of diffuse alveolar hemorrhage. For AAV, treatment includes induction followed by maintenance therapy. Rituximab has an increasing role in the treatment of AAV.

Original languageEnglish (US)
Pages (from-to)587-600
Number of pages14
JournalImmunology and Allergy Clinics of North America
Issue number4
StatePublished - Nov 2012


  • ANCA-associated vasculitis
  • Diffuse alveolar hemorrhage
  • Eosinophilic granulomatosis with polyangiitis
  • Granulomatosis with polyangiitis
  • Microscopic polyangiitis
  • Pulmonary vasculitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Update on Diffuse Alveolar Hemorrhage and Pulmonary Vasculitis'. Together they form a unique fingerprint.

Cite this